PNC Financial Services Group’s Palvella Therapeutics PVLA Stock Holding History
Bought
Maintained
Sold
Other funds holding PVLA
PNC Financial Services Group's PVLA Position: Q3 2026 in Review
PNC Financial Services Group increased its Palvella Therapeutics (PVLA) stake by 32% in Q3 2026, buying an estimated $1.48K and bringing the position to 41 shares worth $5.66K. The position accounts for ﹤0.01% of the portfolio, ranked #4452.
PNC Financial Services Group first reported a position in PVLA in Q1 2018 and has held it in 13 quarters since. The position peaked at $7K in Q1 2018. 199 funds tracked by Wall St. Rank hold PVLA as of Q3 2026.
- PNC Financial Services Group held 41 shares of Palvella Therapeutics worth $5.66K as of Q3 2026.
- PNC Financial Services Group bought 10 Palvella Therapeutics shares in Q3 2026, an estimated $1.48K.
- Palvella Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #4452 holding.
- PNC Financial Services Group first reported a position in Palvella Therapeutics in Q1 2018 and has held it in 13 quarters since.
- PNC Financial Services Group's Palvella Therapeutics position peaked at $7K in Q1 2018.
- 199 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q3 2026.
Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.